Rhythm’s lead biomarker successfully differentiates between cancer and healthy samples
Sep 19, 2019
Next Investors
Sep 19, 2019 |
2 min
New antibodies for the key lead biomarker used in Rhythm Biosciences' (ASX: RHY) ColoSTAT® test can successfully differentiate between cancer and healthy samples, and the test has now been optimised.
Rhythm Biosciences making progress in 1000 patient trial
Aug 7, 2019
Next Investors
Aug 7, 2019 |
4 min
Rhythm Biosciences Ltd (ASX:RHY) is continuing to develop its global, low-cost, lifesaving blood test for the detection of colorectal cancer, ColoSTAT®.
Australia’s top biotechs descend on Queenstown for the 2019 Bioshares Summit
Jul 25, 2019
Next Investors
Jul 25, 2019 |
13 min
Queenstown, the New Zealand extreme sport mecca, hosts the annual Bioshares Biotech Summit, gathering together some of the best long-standing and emerging biotech companies in the country to talk all things trials, tribulations and potential cures for cancer.
